Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-28 Sale | 2024-10-30 4:06 pm | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 15,000 | $48.03 | $720,493 | 135,565 (Indirect Direct) | View |
| 2024-09-18 Sale | 2024-09-20 4:45 pm | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 16,476 | $42.26 | $696,233 | 150,565 (Indirect Direct) | View |
| 2023-07-18 Purchase | 2023-07-20 4:20 pm | Sagimet Biosciences Inc. | SGMT | SEIDENBERG BETH C Director | 46,875 | $16 | $750,000 | 154,859 (Indirect Direct) | View |
| 2023-05-09 Purchase | 2023-05-11 9:13 pm | ACELYRIN Inc. | SLRN | SEIDENBERG BETH C Director 10% Owner | 1,310,000 | $18 | $23,580,000 | 9,873,972 (Indirect Direct) | View |
| 2023-03-30 Purchase | 2023-04-03 4:05 pm | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 2,300 | $7.2395 | $16,651 | 1,949,295 (Indirect) | View |
| 2023-03-28 Purchase | 2023-03-30 4:07 pm | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 23,908 | $7.2441 | $173,192 | 1,946,995 (Indirect) | View |
| 2023-03-24 Purchase | 2023-03-28 4:05 pm | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 3,466 | $7.2424 | $25,102 | 1,923,087 (Indirect) | View |
| 2023-03-17 Purchase | 2023-03-21 4:40 pm | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 89,297 | $7.1325 | $636,915 | 1,919,621 (Indirect) | View |
| 2023-03-15 Purchase | 2023-03-17 4:10 pm | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 92,941 | $7.1043 | $660,278 | 1,830,324 (Indirect) | View |
| 2023-03-10 Purchase | 2023-03-14 4:05 pm | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 48,003 | $7.1555 | $343,485 | 1,737,383 (Indirect) | View |
| 2023-03-03 Purchase | 2023-03-07 4:07 pm | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 1,000 | $7.245 | $7,245 | 1,689,380 (Indirect) | View |
| 2023-03-01 Purchase | 2023-03-03 4:07 pm | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 23,478 | $7.2428 | $170,047 | 1,688,380 (Indirect) | View |
| 2023-02-23 Purchase | 2023-02-27 4:07 pm | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 200 | $7.235 | $1,447 | 1,664,902 (Indirect) | View |
| 2023-02-13 Purchase | 2023-02-15 6:32 pm | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 10,072 | $7.1972 | $72,490 | 1,664,702 (Indirect) | View |
| 2023-02-09 Purchase | 2023-02-13 4:04 pm | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 400 | $7.25 | $2,900 | 1,654,630 (Indirect) | View |
| 2023-02-03 Purchase | 2023-02-09 4:36 pm | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 311,078 | $7.103 | $2,209,588 | 1,654,230 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-07 Option Award | 2024-06-11 9:07 pm | N/A 2034-06-06 | ACELYRIN Inc. | SLRN | SEIDENBERG BETH C Director | 92,158 | $0 | 92,158 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:07 pm | N/A 2034-06-04 | Sagimet Biosciences Inc. | SGMT | SEIDENBERG BETH C Director | 51,459 | $0 | 51,459 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-28 9:50 pm | N/A 2034-05-22 | Progyny Inc. | PGNY | SEIDENBERG BETH C Director | 34,132 | $0 | 5,372,863 (Direct) | View |
| 2024-05-15 Option Award | 2024-05-17 4:17 pm | N/A 2034-05-14 | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 14,000 | $0 | 14,000 (Direct) | View |
| 2024-02-12 Conversion | 2024-02-14 6:56 pm | N/A N/A | Kyverna Therapeutics Inc. | KYTX | SEIDENBERG BETH C Director 10% Owner | 25,112,758 | $0 | 735,984 (Indirect) | View |
Ownership | 2024-02-07 9:55 pm | N/A 2033-11-05 | Kyverna Therapeutics Inc. | KYTX | SEIDENBERG BETH C Director 10% Owner | 0 | $0 | 4,556,883 (Direct) | View |
| 2023-07-18 Option Award | 2023-07-20 4:20 pm | N/A 2029-04-28 | Sagimet Biosciences Inc. | SGMT | SEIDENBERG BETH C Director | 61,979 | $0 | 154,859 (Direct) | View |
| 2023-07-18 Conversion | 2023-07-20 4:20 pm | N/A N/A | Sagimet Biosciences Inc. | SGMT | SEIDENBERG BETH C Director | 156,569,210 | $0 | 154,859 (Indirect) | View |
| 2023-07-18 Disposition | 2023-07-20 4:20 pm | N/A 2029-04-28 | Sagimet Biosciences Inc. | SGMT | SEIDENBERG BETH C Director | 61,979 | $0 | 154,859 (Direct) | View |
Ownership | 2023-07-13 9:11 pm | N/A N/A | Sagimet Biosciences Inc. | SGMT | SEIDENBERG BETH C Director | 0 | $0 | 2,007,459 (Indirect) | View |
| 2023-06-23 Other | 2023-06-27 4:57 pm | N/A N/A | Progyny Inc. | PGNY | SEIDENBERG BETH C Director | 27,446 | $0 | 5,366,177 (Indirect) | View |
| 2023-06-09 Other | 2023-06-13 9:20 pm | N/A N/A | Progyny Inc. | PGNY | SEIDENBERG BETH C Director | 1,917,610 | $0 | 2,188,604 (Indirect) | View |
| 2023-05-31 Option Award | 2023-06-02 8:06 pm | N/A 2033-05-30 | Atara Biotherapeutics Inc. | ATRA | SEIDENBERG BETH C Director | 136,500 | $0 | 2,072,233 (Direct) | View |
| 2023-05-24 Option Award | 2023-06-01 4:20 pm | N/A 2033-05-23 | Progyny Inc. | PGNY | SEIDENBERG BETH C Director | 3,261 | $19.93 | 6,743,661 (Direct) | View |
| 2023-05-24 Option Award | 2023-06-01 4:20 pm | N/A 2033-05-23 | Progyny Inc. | PGNY | SEIDENBERG BETH C Director | 24,825 | $0 | 6,743,661 (Direct) | View |
| 2023-05-10 Option Award | 2023-05-12 4:18 pm | N/A 2033-05-09 | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-05-09 Other | 2023-05-11 9:13 pm | N/A 2033-05-03 | ACELYRIN Inc. | SLRN | SEIDENBERG BETH C Director 10% Owner | 46,486 | $0 | 9,873,972 (Direct) | View |
| 2023-05-09 Conversion | 2023-05-11 9:13 pm | N/A N/A | ACELYRIN Inc. | SLRN | SEIDENBERG BETH C Director 10% Owner | 17,081,458 | $0 | 9,873,972 (Indirect) | View |
| 2023-05-04 Option Award | 2023-05-04 8:21 pm | N/A 2033-05-03 | ACELYRIN Inc. | SLRN | SEIDENBERG BETH C Director 10% Owner | 23,243 | $0 | 23,243 (Direct) | View |
Ownership | 2023-05-04 7:32 pm | N/A N/A | ACELYRIN Inc. | SLRN | SEIDENBERG BETH C Director 10% Owner | 0 | $0 | 8,540,729 (Indirect) | View |
| 2022-03-03 Gift | 2022-10-26 5:40 pm | N/A N/A | Progyny Inc. | PGNY | SEIDENBERG BETH C Director | 22,999 | $0 | 6,962,199 (Direct) | View |
| 2022-10-24 Option Award | 2022-10-26 5:40 pm | N/A 2032-10-23 | Progyny Inc. | PGNY | SEIDENBERG BETH C Director | 22,778 | $0 | 6,962,199 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-27 4:48 pm | N/A 2032-06-22 | Atara Biotherapeutics Inc. | ATRA | SEIDENBERG BETH C Director | 52,000 | $0 | 1,967,233 (Direct) | View |
| 2022-05-24 Option Award | 2022-05-26 4:06 pm | N/A 2032-05-23 | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 9,925 | $0 | 9,925 (Direct) | View |
| 2021-12-22 Other | 2021-12-27 4:37 pm | N/A N/A | Progyny Inc. | PGNY | SEIDENBERG BETH C Director | 34,515 | $0 | 6,746,030 (Indirect) | View |
| 2021-11-17 Other | 2021-11-18 1:16 pm | N/A N/A | Progyny Inc. | PGNY | SEIDENBERG BETH C Director | 1,534,204 | $0 | 1,776,219 (Indirect) | View |
| 2021-09-16 Gift | 2021-10-26 5:32 pm | N/A N/A | Progyny Inc. | PGNY | SEIDENBERG BETH C Director | 32,802 | $0 | 7,640,932 (Direct) | View |
| 2021-10-24 Option Award | 2021-10-26 5:32 pm | N/A 2026-10-23 | Progyny Inc. | PGNY | SEIDENBERG BETH C Director | 22,910 | $0 | 7,640,932 (Direct) | View |
| 2021-07-19 Other | 2021-07-21 6:06 pm | N/A N/A | Progyny Inc. | PGNY | SEIDENBERG BETH C Director | 50,488 | $0 | 7,668,510 (Indirect) | View |
| 2021-05-27 Gift | 2021-06-23 8:20 pm | N/A N/A | Progyny Inc. | PGNY | SEIDENBERG BETH C Director | 84,964 | $0 | 2,364,346 (Direct) | View |
| 2021-06-21 Other | 2021-06-23 8:20 pm | N/A N/A | Progyny Inc. | PGNY | SEIDENBERG BETH C Director | 2,316,044 | $0 | 2,364,346 (Indirect) | View |
| 2021-06-08 Option Award | 2021-06-09 7:16 pm | N/A 2031-06-07 | Atara Biotherapeutics Inc. | ATRA | SEIDENBERG BETH C Director | 28,500 | $0 | 1,932,733 (Direct) | View |
| 2021-05-18 Conversion | 2021-05-18 8:15 pm | N/A N/A | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 1,343,152 | $0 | 1,343,152 (Indirect) | View |